ArriVent BioPharma, Inc.

AVBP · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $1.4B · 77 employees
42
SEC Filings
$29.79
Close 2026-09-09
77
Employees

Business Summary

ArriVent BioPharma is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing differentiated oncology medicines. Its lead candidate, firmonertinib, is an oral EGFR mutant-selective tyrosine kinase inhibitor in pivotal Phase 3 trials for NSCLC with exon 20 insertion and PACC mutations. The pipeline also includes ARR-217 (MRG007), a CDH17-targeting antibody drug conjugate for gastrointestinal cancers, in Phase 1 trials.

Latest Stock Quote

AVBP 2026-09-09 $29.79 O:$30.02 H:$30.26 L:$29.4 Vol:0.3M VWAP:$29.7861
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-10

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001104659-26-024127EDGAR116K words
2025-03-032024-12-310001558370-25-001999EDGAR112K words
2024-03-282023-12-310001558370-24-004280EDGAR125K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-122026-06-300001104659-26-094902EDGAR20K words
2025-11-102025-09-300001104659-25-108847EDGAR20K words
2025-08-112025-06-300001558370-25-010975EDGAR20K words
2025-05-122025-03-310001558370-25-007276EDGAR18K words
2024-11-142024-09-300001558370-24-015624EDGAR20K words
2024-08-142024-06-300001558370-24-012236EDGAR17K words
2024-05-082024-03-310001558370-24-007197EDGAR15K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-120001104659-26-094869EDGAR3K words
2026-03-170001104659-26-029588EDGAR1K words
2026-03-050001104659-26-024112EDGAR3K words
2025-11-100001104659-25-108839EDGAR3K words
2025-09-090001558370-25-011954EDGAR2K words
2025-08-110001558370-25-010974EDGAR3K words
2025-07-210001104659-25-069169EDGAR1K words
2025-07-020001104659-25-065386EDGAR1K words
2025-06-230001104659-25-061375EDGAR1K words
2025-06-200001104659-25-061165EDGAR1K words

42 total filings indexed. 22 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

non-small-cell-lung-cancer-(nsclc) gastrointestinal-cancers solid-tumors oncology recist-1.1-criteria

Company Identity

CIK0001868279
TickerAVBP
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.arrivent.com
Listed2024-01-26

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: bb5829e2c6bfe2c317c80cb47d2db21cb93bcdf71a9dee86a5c3b3d539eaabdf
parent: 6d406183756142c63e3dc8a4bd983fa5cc25ce7639b85b7c427cef97314b88c3
content hash: 0265e03c7440deb6764a1f78f2e7ca86009e20c9fc88b393ead332a5d89a201f
signed: 2026-10-01T12:00:53.291Z
sources: 10 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up AVBP using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on AVBP, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/AVBP (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.